montelukast sodium

Product NDC
71335-1602
11-digit product format
713351602
Labeler code
71335
Product ID
71335-1602_640b5606-8295-4f8d-9929-aedf2f51d227
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
montelukast sodium
Dosage form
TABLET, CHEWABLE
Route
ORAL
Labeler
Bryant Ranch Prepack
Application
ANDA204093
Marketing category
ANDA
Marketing start
2015-05-27
Substance
MONTELUKAST SODIUM
Active strength
4 mg/1
Pharmacologic classes
Leukotriene Receptor Antagonist [EPC], Leukotriene Receptor Antagonists [MoA]
NDC exclude flag
No
Listing certified through
2026-12-31
Current FDA listing
Yes

Related Records

Related UNII Ingredients

UNIIPreferred termRegistry numberMatched term
U1O3J18SFLMONTELUKAST SODIUM151767-02-1MONTELUKAST SODIUM

Packages

Package NDC11-digit formatDescriptionMarketing startSampleExclude flagStatus
71335-1602-17133516020130 TABLET, CHEWABLE in 1 BOTTLE (71335-1602-1) 2020-05-13NoNoHistorical
71335-1602-27133516020290 TABLET, CHEWABLE in 1 BOTTLE (71335-1602-2) 2020-05-13NoNoHistorical
71335-1602-37133516020360 TABLET, CHEWABLE in 1 BOTTLE (71335-1602-3) 2022-02-14NoNoHistorical

Related DailyMed Labels

TitleManufacturerEffective dateTypeVersion
montelukast sodiumBryant Ranch Prepack2024-10-07HUMAN PRESCRIPTION DRUG LABEL5